Magnetic Ratcheting Cytometry Towards Manafacturing Scale Separations Of “Best In Class” Cart-T Cells
January 15-19, 2017
Adoptive cell therapies taking advantage of engineered Chimeric Antigen Receptors (CAR) or T-Cell Receptors (TCR) have shown incredible potential as “living drugs” that achieve personalized immunotherapies for cancer patients. However, variations in T cell transduction efficiency during genetic modification can lead to widely varied levels of expression (~2-orders of magnitude) which can possibly dilute therapeutic effectiveness and potentially contribute to off-tumor toxicity. While research has shown that isolation of cell sub-populations with tightly controlled expression could lead to improved therapies, limitations of current cell separation technologies prevent implementation at manufacturing scale workflows. Quantitative separation techniques (e.g. fluorescence assisted cell separation-FACS) do not scale for production of therapeutic doses, and magnetic assisted cell separation (MACS) techniques do not allow precise selection of cell sub-populations based on surface expression. Because of these limitations, enrichment of “best in class” CAR-T/TCR sub-populations at manufacturing scale throughputs remains impractical and non-economical.
 Chang ZL, Silver PA, Chen YY. Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors. J Transl Med. 2015;13:161. doi:10.1186/s12967-015-0519-8.
 Carels N, Spinassé LB, Tilli TM, Tuszynski JA. Toward precision medicine of breast cancer. Theor Biol Med Model. 2016;13:7. doi:10.1186/s12976-016-0035-4.
 Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Investig 2008;118: 294–305.
Please click Additional Files below to see the full abstract.
Coleman Murray, Edward Pao, Ximin Chen, Yvonne Chen, and Dino Di Carlo, "Magnetic Ratcheting Cytometry Towards Manafacturing Scale Separations Of “Best In Class” Cart-T Cells" in "Scale-up and Manufacturing of Cell-based Therapies V", Tom Brieva, Celgene Cellular Therapeutics William Miller, Northwestern University Chris Mason, University College London Eds, ECI Symposium Series, (2017). http://dc.engconfintl.org/cellbasedtherapies_v/110
This document is currently not available here.